Latest Insider Transactions at Agilon Health, Inc. (AGL)
This section provides a real-time view of insider transactions for Agilon Health, Inc. (AGL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of agilon health, inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of agilon health, inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 14
2022
|
Steven Sell CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
48,765
+50.0%
|
-
|
Apr 14
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,546
+14.89%
|
-
|
Apr 14
2022
|
Michael L Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,936
+4.18%
|
-
|
Apr 14
2022
|
Glenn Sobotka Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,439
+29.97%
|
-
|
Apr 14
2022
|
Girish Venkatachaliah Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,837
+39.98%
|
-
|
Apr 14
2022
|
Ronald A Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,936
+0.28%
|
-
|
Apr 14
2022
|
John William Wulf Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,936
+5.32%
|
-
|
Apr 07
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
2,706
-4.06%
|
$67,650
$25.01 P/Share
|
Mar 16
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
37,155
-35.8%
|
$743,100
$20.2 P/Share
|
Mar 16
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,155
+26.36%
|
$111,465
$3.0 P/Share
|
Mar 16
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
197,291
-42.96%
|
$3,945,820
$20.41 P/Share
|
Mar 16
2022
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
197,291
+30.05%
|
$197,291
$1.0 P/Share
|
Mar 15
2022
|
John William Wulf Director |
SELL
Open market or private sale
|
Direct |
30,808
-11.01%
|
$585,352
$19.11 P/Share
|
Mar 15
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
79,457
-54.4%
|
$1,509,683
$19.25 P/Share
|
Mar 15
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
79,457
+35.23%
|
$238,371
$3.0 P/Share
|
Mar 14
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
81,537
-23.05%
|
$1,630,740
$20.5 P/Share
|
Mar 14
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
81,537
+35.5%
|
$244,611
$3.0 P/Share
|
Dec 31
2021
|
Theodore Halkias Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,162
-17.62%
|
$31,374
$27.55 P/Share
|
Dec 31
2021
|
Theodore Halkias Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,162
+14.98%
|
$1,162
$1.0 P/Share
|
Dec 30
2021
|
Theodore Halkias Chief Business Officer |
SELL
Open market or private sale
|
Direct |
12,113
-69.03%
|
$327,051
$27.54 P/Share
|
Dec 30
2021
|
Theodore Halkias Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,113
+40.84%
|
$12,113
$1.0 P/Share
|
Dec 29
2021
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
4,685
-6.57%
|
$121,810
$26.54 P/Share
|
Dec 28
2021
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
14,055
-16.47%
|
$365,430
$26.72 P/Share
|
Dec 27
2021
|
Theodore Halkias Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,583
-50.68%
|
$150,741
$27.53 P/Share
|
Dec 27
2021
|
Theodore Halkias Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,583
+33.63%
|
$5,583
$1.0 P/Share
|
Dec 23
2021
|
Theodore Halkias Chief Business Officer |
SELL
Open market or private sale
|
Direct |
21,142
-79.55%
|
$570,834
$27.52 P/Share
|
Dec 23
2021
|
Theodore Halkias Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,142
+44.31%
|
$21,142
$1.0 P/Share
|
Dec 17
2021
|
Joan Danieley Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
21,481
-44.06%
|
$472,582
$22.62 P/Share
|
Dec 17
2021
|
Joan Danieley Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,481
+44.39%
|
$85,924
$4.45 P/Share
|
Dec 16
2021
|
Joan Danieley Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
3,519
-39.31%
|
$80,937
$23.14 P/Share
|
Dec 16
2021
|
Joan Danieley Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,519
+28.22%
|
$14,076
$4.45 P/Share
|
Dec 15
2021
|
Joan Danieley Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
25,000
-57.19%
|
$550,000
$22.94 P/Share
|
Dec 15
2021
|
Joan Danieley Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+45.1%
|
$100,000
$4.45 P/Share
|
Nov 17
2021
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
4,685
-5.2%
|
$117,125
$25.26 P/Share
|
Nov 16
2021
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
4,685
-4.95%
|
$117,125
$25.37 P/Share
|
Nov 04
2021
|
Glenn Sobotka Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
150,000
-97.87%
|
$3,750,000
$25.19 P/Share
|
Nov 04
2021
|
Glenn Sobotka Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+49.46%
|
$1,050,000
$7.57 P/Share
|
Nov 04
2021
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,560
-16.38%
|
$464,000
$25.19 P/Share
|
Nov 03
2021
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
300
-0.26%
|
$7,500
$25.0 P/Share
|
Sep 14
2021
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
121,001
-31.6%
|
$3,388,028
$28.98 P/Share
|
Sep 14
2021
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
121,001
+24.01%
|
$121,001
$1.0 P/Share
|
Sep 14
2021
|
Lisa Dombro Exper. & Innovation Officer |
SELL
Open market or private sale
|
Direct |
61,543
-83.73%
|
$1,723,204
$28.98 P/Share
|
Sep 14
2021
|
Lisa Dombro Exper. & Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
61,543
+45.57%
|
$61,543
$1.0 P/Share
|
Sep 14
2021
|
Theodore Halkias Chief Business Officer |
SELL
Open market or private sale
|
Indirect |
100,000
-100.0%
|
$2,800,000
$28.98 P/Share
|
Sep 14
2021
|
Theodore Halkias Chief Business Officer |
SELL
Open market or private sale
|
Direct |
58,553
-91.51%
|
$1,639,484
$28.98 P/Share
|
Sep 14
2021
|
Theodore Halkias Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
58,553
+47.78%
|
$58,553
$1.0 P/Share
|
Sep 14
2021
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
11,475
-67.86%
|
$321,300
$28.98 P/Share
|
Sep 14
2021
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,475
+40.43%
|
$45,900
$4.5 P/Share
|
Sep 14
2021
|
Sharad Mansukani Director |
SELL
Open market or private sale
|
Direct |
156,250
-11.28%
|
$4,375,000
$28.98 P/Share
|
Sep 14
2021
|
Sharad Mansukani Director |
BUY
Exercise of conversion of derivative security
|
Direct |
156,250
+10.13%
|
$156,250
$1.0 P/Share
|